Terns Pharmaceuticals, Inc. - TERN

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$86.38M
QoQ value delta ($000)
-$7.174B (-98.81%)
Implied price effect (QoQ)
+0.22%
Shares
Total shares
1,638,247
QoQ shares delta
-136,375,439 (-98.81%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (TERN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
JANUS HENDERSON GROUP PLC 77,511 1,470,057 0.04%
CIBRA Capital Ltd 7,983 151,440 3.85%
MIZUHO SECURITIES USA LLC 584 11,083 0.01%
CWM, LLC 219 4,172 0.0%
IFP Advisors, Inc 75 1,424 0.0%
Sunbelt Securities, Inc. 3 71 0.0%